Y Mabs Therapeutics Stock Investor Sentiment

YMAB Stock  USD 4.67  0.06  1.27%   
About 75% of Y MAbs' investor base is looking to short. The analysis of the overall investor sentiment regarding Y mAbs Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Y MAbs' historical and current headlines, can help investors time the market. In addition, many technical investors use Y mAbs Therapeutics stock news signals to limit their universe of possible portfolio assets.

Comfort Level 25

 Alarmed

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Y MAbs' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Y mAbs Therapeutics.

YMAB Historical Sentiment

Although Y MAbs' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding YMAB, such as negative comments on social media and news outlets, may cause fear in the market and push Y MAbs' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of YMAB.
  

Y MAbs Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Y MAbs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at globenewswire.com         
Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast
Macroaxis News: globenewswire.com
over three months ago at gurufocus.com         
Y-mAbs Therapeutics Inc Q2 2024 Earnings Call Highlights Revenue Growth Driven by ...
Gurufocus Stories at Macroaxis
over three months ago at thelincolnianonline.com         
Y-mAbs Therapeutics, Inc. Receives 21.14 Consensus Target Price from Brokerages
news
over three months ago at www.macroaxis.com         
Disposition of 722 shares by Ber Gerard of Y MAbs at 12.0 subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
Y-mAbs to Participate in Upcoming Investor Conferences in October
Yahoo News
over three months ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over three months ago at finance.yahoo.com         
While shareholders of Y-mAbs Therapeutics are in the black over 1 year, those who bought a week ago ...
Yahoo News
over three months ago at simplywall.st         
Founder Thomas Gad Sold A Bunch Of Shares In Y-mAbs Therapeutics
Simply Wall St News at Macroaxis
over three months ago at www.macroaxis.com         
Disposition of 22831 shares by Thomas Gad of Y MAbs at 4.38 subject to Rule 16b-3
Macroaxis News
over three months ago at thelincolnianonline.com         
Insider Selling Y-mAbs Therapeutics, Inc. Insider Sells 65,000 Shares of Stock
news
over three months ago at thelincolnianonline.com         
Y-mAbs Therapeutics, Inc. Insider Thomas Gad Sells 30,000 Shares
news
over six months ago at thelincolnianonline.com         
Y-mAbs Therapeutics Trading Up 8.1
news
over six months ago at www.macroaxis.com         
Disposition of 30000 shares by Thomas Gad of Y MAbs at 12.97 subject to Rule 16b-3
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 65000 shares by Thomas Gad of Y MAbs at 13.47 subject to Rule 16b-3
Macroaxis News
over six months ago at simplywall.st         
Y-mAbs Therapeutics, Inc. Held Back By Insufficient Growth Even After Shares Climb 33
Simply Wall St News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Y MAbs that are available to investors today. That information is available publicly through YMAB media outlets and privately through word of mouth or via YMAB internal channels. However, regardless of the origin, that massive amount of YMAB data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Y MAbs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Y MAbs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Y MAbs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Y MAbs alpha.

Y MAbs Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insider Trading
01/06/2025
2
Acquisition by Larocca John of 21500 shares of Y MAbs subject to Rule 16b-3
01/17/2025
3
Y-mAbs Therapeutics, Inc. Receives 20.89 Average Price Target from Analysts - MarketBeat
02/07/2025
4
Y-mAbs to Announce Fourth Quarter and Full Year 2024 Financial and Operating Results on March ...
02/20/2025
5
Shareholders in Y-mAbs Therapeutics are in the red if they invested five years ago
02/26/2025
6
Y-mAbs Announces Publication of Phase 2 Interim Results in Nature Communications
03/03/2025
7
Y-mAbs Reports Fourth Quarter 2024 Financial Results and Recent Corporate Developments
03/04/2025
8
Q4 2024 Y-mAbs Therapeutics Inc Earnings Call Transcript
03/05/2025
9
Disposition of 10810 shares by Thomas Gad of Y MAbs at 5.23 subject to Rule 16b-3
03/07/2025

Complementary Tools for YMAB Stock analysis

When running Y MAbs' price analysis, check to measure Y MAbs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Y MAbs is operating at the current time. Most of Y MAbs' value examination focuses on studying past and present price action to predict the probability of Y MAbs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Y MAbs' price. Additionally, you may evaluate how the addition of Y MAbs to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bonds Directory
Find actively traded corporate debentures issued by US companies
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges